Dynamk Capital LLC

04/11/2024 | Press release | Archived content

Virica Biotech Selected as a Lead Project as Part of NIIMBL's $10M Biomanufacturing Projects

Portfolio company, Virica Biotech has been included in a NIIMBL (The National Institute for Innovation in Manufacturing Biopharmaceuticals) $10M program as a lead project in a total of 8 biomanufacturing Projects. Virica's VSE platform helps to increase viral vector yield by reducing innate cellular antiviral defenses.

For more information on the project and all the participating companies, read the full announcement.

Dynamk Capital LLC published this content on April 11, 2024, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on April 06, 2026 at 12:14 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]